(Q41945322)

14 October 2017

title

Spectacular suicide associated with mefloquine (English)

1 reference

14 October 2017

0 references

Clotilde Rougé-Maillart

6

object named as

Clotilde Rougé-Maillart

1 reference

14 October 2017

1

Nathalie Jousset

1 reference

14 October 2017

Michel Guilleux

2

1 reference

14 October 2017

Ludovic de Gentile

3

1 reference

14 October 2017

Anne Le Bouil

4

1 reference

14 October 2017

Alain Turcant

5

1 reference

14 October 2017

language of work or name

French

0 references

publication date

1 May 2006

1 reference

14 October 2017

1 reference

14 October 2017

volume

35

1 reference

14 October 2017

issue

5 Pt 1

1 reference

14 October 2017

page(s)

789-792

1 reference

Acute psychosis after mefloquine

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

Neuropsychiatric events during prophylactic use of mefloquine before travelling

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

Mefloquine for malaria chemoprophylaxis 1992-1998: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974691-7

7 January 2021

10.1016/S0755-4982(06)74691-7

Identifiers

DOI

1 reference

14 October 2017

1 reference